Acute cecal tympany during chemical restraint in free-ranging capybara (Hydrochoerus hydrochaeris) - iatrogenic cause and treatment

The occurrence of acute tympany, probable cause and treatment are being discussed for the first time in Hydrochoerus hydrochaeris, commonly known as the capybara. As part of a capybara population control study, adult male and female (n=18), prior to intervention, were physically confined and subsequently chemically immobilized with a ketamine dexmedetomidine (KD) association. Procedures included health exams, biomaterial collection, and ID markings. For surgical events, the animals were maintained under volatile anesthesia with Isoflurane. One animal, during anesthetic recovery, developed tachycardia and tachypnea, with cyanotic mucosa, and a low SPO2. During auscultation and percussion/palpation a taut abdominal wall was recognized. Shortly thereafter, the animal suffered a cardiorespiratory arrest and failed resuscitation. Immediately performed necropsy suggested death by acute respiratory and circulatory failure due to exerted pressure against the diaphragm and compression of major blood vessels, leading to hypoxia and hypovolemic shock, secondary to cecal dilation. Three animals under general anesthesia demonstrated moderate bloating and were treated by trans-abdominal catheterization for cecal decompression, successfully preventing any potential development of severe tympany. Conclusion: During chemical restraint all animals demonstrated bloat of varies degrees, suggesting iatrogenic cause brought about by adverse effects of anesthetic agents. Acute cecal tympany in sedated capybaras must be anticipated and closely monitored to prevent fatal outcome. Trans-abdominal catheterization into the cecum proved effective in treating bloat.

Acute cecal tympany during chemical restraint in free-ranging capybara (Hydrochoerus hydrochaeris) - iatrogenic cause and treatment

The occurrence of acute tympany, probable cause and treatment are being discussed for the first time in Hydrochoerus hydrochaeris, commonly known as the capybara. As part of a capybara population control study, adult male and female (n=18), prior to intervention, were physically confined and subsequently chemically immobilized with a ketamine dexmedetomidine (KD) association. Procedures included health exams, biomaterial collection, and ID markings. For surgical events, the animals were maintained under volatile anesthesia with Isoflurane. One animal, during anesthetic recovery, developed tachycardia and tachypnea, with cyanotic mucosa, and a low SPO2. During auscultation and percussion/palpation a taut abdominal wall was recognized. Shortly thereafter, the animal suffered a cardiorespiratory arrest and failed resuscitation. Immediately performed necropsy suggested death by acute respiratory and circulatory failure due to exerted pressure against the diaphragm and compression of major blood vessels, leading to hypoxia and hypovolemic shock, secondary to cecal dilation. Three animals under general anesthesia demonstrated moderate bloating and were treated by trans-abdominal catheterization for cecal decompression, successfully preventing any potential development of severe tympany. Conclusion: During chemical restraint all animals demonstrated bloat of varies degrees, suggesting iatrogenic cause brought about by adverse effects of anesthetic agents. Acute cecal tympany in sedated capybaras must be anticipated and closely monitored to prevent fatal outcome. Trans-abdominal catheterization into the cecum proved effective in treating bloat.(AU)

C-Peptides for diagnostics and therapy: a veterinary medicine point of view / Peptídeos-C para diagnóstico e terapia: um ponto de vista na medicina veterinária

Empirical studies proved that C-peptides are performing numerous intrinsic biological roles, and serve as a marker for pancreatic performance analysis. Since the last decade, C-peptide assays for differential diagnosis in veterinary diabetic patients are becoming more available, but still only for a very limited number of species. Studies on C-peptide as a diagnostic tool, therapy for associated complications, or as replacement therapies for C-peptide deficiency still showed not to be a common practice in veterinary medicine. This review was conducted to determine the potential importance of C-peptide in Veterinary Medicine, relevant in the diagnosis of diabetes and for other metabolic processes, as well as its proposed therapeutic benefits. Numerous articles were identified that reported positive results in their experimental studies, whether C-peptide as a biomarker for pancreatic performance in dogs, cats, and horses, as a non-invasive method to monitor nutritional status in primates, or to investigate its potential therapeutic benefits for diabetes-related illnesses.(AU)

Os estudos empíricos provaram que o peptídeo C realiza várias funções biológicas intrínsecas e serve também como um marcador para a análise de desempenho do pâncreas. Nesta última década os ensaios peptídeo C para o diagnóstico diferencial em doentes diabéticos veterinários estão mais disponíveis, contudo apenas em um limitado número de espécies. Estudos sobre C-peptídeo como ferramenta de diagnóstico, terapia de complicações associadas ou como terapias de reposição na sua deficiência ainda não é prática comum na Medicina Veterinária. Esta avaliação foi realizada para determinar a importância potencial de peptídeo C na Medicina Veterinária, relevante no diagnóstico de diabetes e também em outros processos metabólicos, assim como os benefícios terapêuticos propostos. Foram identificados numerosos artigos que reportaram resultados positivos nos seus estudos experimentais, quer o peptídeo C fosse utilizado como biomarcador para o desempenho do pâncreas em cães, gatos e cavalos, como um método não invasivo para monitorar o estado nutricional em primatas, quer para investigar o seu potencial terapêutico benéfico para doenças relacionadas ao diabetes.(AU)

C-Peptides for diagnostics and therapy: a veterinary medicine point of view / Peptídeos-C para diagnóstico e terapia: um ponto de vista na medicina veterinária

Empirical studies proved that C-peptides are performing numerous intrinsic biological roles, and serve as a marker for pancreatic performance analysis. Since the last decade, C-peptide assays for differential diagnosis in veterinary diabetic patients are becoming more available, but still only for a very limited number of species. Studies on C-peptide as a diagnostic tool, therapy for associated complications, or as replacement therapies for C-peptide deficiency still showed not to be a common practice in veterinary medicine. This review was conducted to determine the potential importance of C-peptide in Veterinary Medicine, relevant in the diagnosis of diabetes and for other metabolic processes, as well as its proposed therapeutic benefits. Numerous articles were identified that reported positive results in their experimental studies, whether C-peptide as a biomarker for pancreatic performance in dogs, cats, and horses, as a non-invasive method to monitor nutritional status in primates, or to investigate its potential therapeutic benefits for diabetes-related illnesses.(AU)

Os estudos empíricos provaram que o peptídeo C realiza várias funções biológicas intrínsecas e serve também como um marcador para a análise de desempenho do pâncreas. Nesta última década os ensaios peptídeo C para o diagnóstico diferencial em doentes diabéticos veterinários estão mais disponíveis, contudo apenas em um limitado número de espécies. Estudos sobre C-peptídeo como ferramenta de diagnóstico, terapia de complicações associadas ou como terapias de reposição na sua deficiência ainda não é prática comum na Medicina Veterinária. Esta avaliação foi realizada para determinar a importância potencial de peptídeo C na Medicina Veterinária, relevante no diagnóstico de diabetes e também em outros processos metabólicos, assim como os benefícios terapêuticos propostos. Foram identificados numerosos artigos que reportaram resultados positivos nos seus estudos experimentais, quer o peptídeo C fosse utilizado como biomarcador para o desempenho do pâncreas em cães, gatos e cavalos, como um método não invasivo para monitorar o estado nutricional em primatas, quer para investigar o seu potencial terapêutico benéfico para doenças relacionadas ao diabetes.(AU)

C-Peptides for diagnostics and therapy: a veterinary medicine point of view

ABSTRACT: Empirical studies proved that C-peptides are performing numerous intrinsic biological roles, and serve as a marker for pancreatic performance analysis. Since the last decade, C-peptide assays for differential diagnosis in veterinary diabetic patients are becoming more available, but still only for a very limited number of species. Studies on C-peptide as a diagnostic tool, therapy for associated complications, or as replacement therapies for C-peptide deficiency still showed not to be a common practice in veterinary medicine. This review was conducted to determine the potential importance of C-peptide in Veterinary Medicine, relevant in the diagnosis of diabetes and for other metabolic processes, as well as its proposed therapeutic benefits. Numerous articles were identified that reported positive results in their experimental studies, whether C-peptide as a biomarker for pancreatic performance in dogs, cats, and horses, as a non-invasive method to monitor nutritional status in primates, or to investigate its potential therapeutic benefits for diabetes-related illnesses.

RESUMO: Os estudos empíricos provaram que o peptídeo C realiza várias funções biológicas intrínsecas e serve também como um marcador para a análise de desempenho do pâncreas. Nesta última década os ensaios peptídeo C para o diagnóstico diferencial em doentes diabéticos veterinários estão mais disponíveis, contudo apenas em um limitado número de espécies. Estudos sobre C-peptídeo como ferramenta de diagnóstico, terapia de complicações associadas ou como terapias de reposição na sua deficiência ainda não é prática comum na Medicina Veterinária. Esta avaliação foi realizada para determinar a importância potencial de peptídeo C na Medicina Veterinária, relevante no diagnóstico de diabetes e também em outros processos metabólicos, assim como os benefícios terapêuticos propostos. Foram identificados numerosos artigos que reportaram resultados positivos nos seus estudos experimentais, quer o peptídeo C fosse utilizado como biomarcador para o desempenho do pâncreas em cães, gatos e cavalos, como um método não invasivo para monitorar o estado nutricional em primatas, quer para investigar o seu potencial terapêutico benéfico para doenças relacionadas ao diabetes.